Protagonist therapeutics, inc. (PTGX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Jun'15
License and collaboration revenue - related party

2,318

231

3,629

11,162

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

License and collaboration revenue - related party

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

License and collaboration revenue - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Operating expenses:
Research and development

71,327

65,003

63,341

58,193

56,573

59,497

56,972

55,995

50,267

46,181

43,280

37,673

31,362

25,705

20,040

16,776

0

0

0

General and administrative

16,561

15,749

15,158

14,504

13,819

13,697

13,252

12,484

12,430

11,779

11,282

10,266

8,537

6,961

5,250

4,459

0

0

0

Total operating expenses

87,888

80,752

78,499

72,697

70,392

73,194

70,224

68,479

62,697

57,960

54,562

47,939

39,899

32,666

25,290

21,235

0

0

0

Loss from operations

-85,570

-80,521

-78,634

-70,856

-48,688

-42,269

-30,370

-25,961

-31,853

-37,897

-45,781

-47,939

-39,899

-32,666

-25,290

-21,235

0

0

0

Interest income

2,608

2,813

2,759

2,757

2,729

2,566

2,267

1,768

1,344

948

628

527

402

242

94

0

0

0

-

Interest expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of redeemable convertible preferred stock tranche and warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

4,719

4,148

4,284

0

0

0

Other expense, net

0

-

-

-

0

-

-

-

-

-

-

-

-

-

0

0

-

-

-

Loss before income tax expense

-83,862

-77,878

-75,898

-68,122

-45,982

-39,723

0

0

0

-

-

-

-

-

-

-

-

-

-

Income tax expense

-707

-700

-2,347

-2,245

-616

-799

0

0

0

-

-

-

-

-

-

-

-

-

-

Net loss

-83,164

-77,187

-73,551

-65,877

-45,366

-38,924

-28,111

-24,201

-30,517

-36,957

-45,153

-47,412

-39,531

-37,177

-29,378

-25,513

0

0

0

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-37,735

-29,972

-25,814

0

0

0

Net loss per share, basic and diluted

-0.72

-0.61

-0.61

-1.18

-0.58

-0.59

-0.38

-0.41

-0.36

-0.07

-0.29

-0.89

-0.84

55.10

-0.87

-19.07

-40.96

-12.79

-13.78

Weighted-average shares used to compute net loss per share, basic and diluted

27,703

27,658

26,956

24,662

24,297

24,226

22,912

21,207

21,112

20,224

16,911

16,875

16,766

16,852

8,483

383

287

272

233